Clinical trial

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in…

NCT00030563 · University of Washington, Other · Completed

Key facts

NCT number NCT00030563
Title Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
Official title A Phase II Study Of Adjuvant Intravenous Irinotecan Following Resection With Or Without Radiofrequency Ablation (RFA), Of Hepatic Metastases From Colorectal Carcinoma
Lead sponsor University of Washington, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer, Metastatic Cancer
Intervention type Drug, Procedure
Interventions irinotecan hydrochloride, adjuvant therapy, conventional surgery, radiofrequency ablation
Start date May 1, 2001
Primary completion Oct 1, 2004
Completion Oct 1, 2005
First posted Jan 27, 2003
Last update posted Apr 17, 2017
Countries Canada, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies